Price T Rowe Associates Inc Organogenesis Holdings Inc. Transaction History
Price T Rowe Associates Inc
- $867 Billion
- Q4 2024
A detailed history of Price T Rowe Associates Inc transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 28,899 shares of ORGO stock, worth $102,013. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,899
Previous 53,439
45.92%
Holding current value
$102,013
Previous $153,000
39.22%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding ORGO
# of Institutions
124Shares Held
62MCall Options Held
4.3KPut Options Held
3.9K-
Soleus Capital Management, L.P. Greenwich, CT12.5MShares$44.1 Million2.78% of portfolio
-
Morgan Stanley New York, NY11.8MShares$41.8 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$18 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.59MShares$12.7 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA3.08MShares$10.9 Million0.03% of portfolio
About Organogenesis Holdings Inc.
- Ticker ORGO
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 130,888,000
- Market Cap $462M
- Description
- Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...